NR3C1 and cancer: Pin1 expression is augmented in both cancer (14–16) and inflammation (17), two pathophysiological states associated with altered GR function (17), and associates with other nuclear hormone receptors (NHRs) including the androgen receptor (18), estrogen receptor (19), Nur77 (20), PPARγ (21) and retinoic acid receptor (22).